ALK and inflammatory myofibroblastic tumor: The SQSTM1-ALK fusion has been identified in other cancers, such as inflammatory myofibroblastic tumors (IMT), epithelioid fibrous histiocytoma (Dickson et al., 2018), and large B-cell lymphoma (d’Amore et al., 2013).